Neurocrine Biosciences Inc (NBIX) Ownership

125.65 ↑0.65 (0.52%)

As of December 31, 1969, 7:00pm EST.

Institutions
Mutual Funds

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Neurocrine Biosciences Inc (NBIX), owning a total of 14.2 million shares. Combined, the top 39 institutional holders of NBIX own 78.85% of the company with a total of 79.3 million shares.

In the latest ownership report on June 30th 2024, the top 39 institutional holders increased their combined ownership of NBIX by 488 thousand shares. 12 institutions bought 2,611,442 total additional shares and increased their ownership by an average of 14.42%. However 9 institutions sold 2,123,771 total shares and decreased their ownership by an average of 12.23%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Neurocrine Biosciences increased by a net total of 487,671 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	14.016%	3.123%	14,190,708	429,738	2024-06-30
Vanguard Group Inc	9.933%	1.264%	10,056,446	125,520	2024-06-30
State Street Corp	4.552%	15.499%	4,608,357	618,396	2024-06-30
Morgan Stanley - Brokerage Accounts	3.052%	-25.211%	3,089,738	-1,041,534	2024-06-30
Renaissance Technologies Corp	2.438%	9.615%	2,468,146	216,500	2024-06-30
JPMorgan Chase & Co	2.334%	2.947%	2,362,735	67,627	2024-06-30
Bellevue Group AG	1.875%	-7.648%	1,898,640	-157,234	2024-06-30
Geode Capital Management, LLC	1.797%	6.180%	1,819,622	105,908	2024-06-30
T. Rowe Price Associates, Inc.	1.777%	-1.205%	1,798,848	-21,948	2024-06-30
Dodge & Cox	1.265%	1.231%	1,280,820	15,576	2024-06-30
Amvescap Plc.	1.243%	10.657%	1,258,104	121,162	2024-06-30
AQR Capital Management LLC	1.208%	22.968%	1,223,055	228,444	2024-06-30
Goldman Sachs Group Inc	1.119%	46.004%	1,132,589	356,862	2024-06-30
DSM Capital Partners LLC	0.986%	-12.167%	997,784	-138,218	2024-06-30
Brown Advisory Holdings Inc	0.983%	-8.556%	995,214	-93,119	2024-06-30
Armistice Capital, LLC	0.966%	-4.420%	978,488	-45,251	2024-06-30
HHG PLC	0.959%	-29.547%	971,203	-407,310	2024-06-30
Rock Springs Capital Management LP	0.928%	-10.892%	940,000	-114,900	2024-06-30
Bank of New York Mellon Corp	0.923%	1.419%	934,404	13,069	2024-06-30
UBS Asset Mgmt Americas Inc	0.901%	52.157%	912,064	312,640	2024-06-30
Wellington Management Company LLP	0.891%	-10.387%	899,493	-104,257	2024-06-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	14.016%	3.123%	14,190,708	429,738	2024-06-30
Vanguard Group Inc	9.933%	1.264%	10,056,446	125,520	2024-06-30
State Street Corp	4.552%	15.499%	4,608,357	618,396	2024-06-30
State Street Corporation	3.951%	-1.806%	3,989,961	-73,375	2024-03-31
Morgan Stanley - Brokerage Accounts	3.052%	-25.211%	3,089,738	-1,041,534	2024-06-30
Point72 Asset Management, L.P.	2.563%	2,215.170%	2,578,128	2,466,770	2023-09-30
Renaissance Technologies Corp	2.438%	9.615%	2,468,146	216,500	2024-06-30
JPMorgan Chase & Co	2.334%	2.947%	2,362,735	67,627	2024-06-30
Bellevue Group AG	1.875%	-7.648%	1,898,640	-157,234	2024-06-30
Geode Capital Management, LLC	1.797%	6.180%	1,819,622	105,908	2024-06-30
T. Rowe Price Associates, Inc.	1.777%	-1.205%	1,798,848	-21,948	2024-06-30
Avidity Partners Management LP	1.824%	-4.079%	1,780,000	-75,700	2022-12-31
Eaton Vance Management	1.382%	-8.288%	1,347,820	-121,797	2022-09-30
Citadel Advisors Llc	1.330%	175.357%	1,306,273	831,881	2023-06-30
Dodge & Cox	1.265%	1.231%	1,280,820	15,576	2024-06-30
Millennium Management LLC	1.275%	49.163%	1,268,266	418,008	2023-09-30
Amvescap Plc.	1.243%	10.657%	1,258,104	121,162	2024-06-30
AQR Capital Management LLC	1.208%	22.968%	1,223,055	228,444	2024-06-30
Deerfield Management Co	1.203%	0.000%	1,209,714	0	2023-09-30
Amundi	1.211%	-2.604%	1,190,026	-31,815	2023-06-30
Woodline Partners LP	1.173%	188.991%	1,152,189	753,495	2023-06-30
Goldman Sachs Group Inc	1.119%	46.004%	1,132,589	356,862	2024-06-30
Pictet Asset Manangement SA	1.071%	-10.868%	1,081,449	-131,864	2024-03-31
Franklin Resources Inc	1.095%	-10.907%	1,052,235	-128,820	2022-09-30
American Century Companies Inc	1.032%	-8.198%	1,013,744	-90,523	2023-09-30
T. Rowe Price Investment Management,Inc.	1.044%	0.000%	1,008,326	1,008,326	2022-09-30
DSM Capital Partners LLC	0.986%	-12.167%	997,784	-138,218	2024-06-30
Brown Advisory Holdings Inc	0.983%	-8.556%	995,214	-93,119	2024-06-30
Armistice Capital, LLC	0.966%	-4.420%	978,488	-45,251	2024-06-30
HHG PLC	0.959%	-29.547%	971,203	-407,310	2024-06-30
Rock Springs Capital Management LP	0.928%	-10.892%	940,000	-114,900	2024-06-30
NORGES BANK	0.959%	21.798%	935,915	167,499	2022-12-31
Bank of New York Mellon Corp	0.923%	1.419%	934,404	13,069	2024-06-30
Los Angeles Capital Management LLC	0.913%	65.953%	918,391	364,986	2023-12-31
Congress Asset Management Company, LLP	0.950%	-16.117%	917,825	-176,352	2022-12-31
UBS Asset Mgmt Americas Inc	0.901%	52.157%	912,064	312,640	2024-06-30
Wellington Management Company LLP	0.891%	-10.387%	899,493	-104,257	2024-06-30
Northern Trust Corp	0.897%	1.633%	875,610	14,068	2023-03-31
Polar Capital Holdings PLC	0.831%	157.179%	835,833	510,833	2023-12-31

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Neurocrine Biosciences Inc (NBIX), owning a total of 3.2 million shares. Combined, the top 38 mutual fund holders of NBIX own 37.37% of the company with a total of 37.4 million shares.

In the latest ownership report on October 31st 2024, the top 38 fund holders increased their combined ownership of NBIX by 48 thousand shares. 2 funds bought 2,144 total additional shares and increased their ownership by an average of 0.07%. However 5 funds sold 50,375 total shares and decreased their ownership by an average of 1.17%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Neurocrine Biosciences decreased by a net total of -48,231 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
iShares Core S&P Mid-Cap ETF	3.140%	0.054%	3,179,320	1,728	2024-10-31
SPDR® S&P Biotech ETF	1.471%	-1.424%	1,489,130	-21,504	2024-10-31
iShares Biotechnology ETF	0.686%	-0.746%	694,961	-5,222	2024-10-31
iShares MSCI USA Min Vol Factor ETF	0.649%	-0.189%	656,595	-1,240	2024-10-31
iShares S&P Mid-Cap 400 Growth ETF	0.622%	-0.049%	629,574	-309	2024-10-31
State St Russell Sm/Mid Cp® Indx NL Cl C	0.608%	-3.464%	615,853	-22,100	2024-10-31
iShares Russell Mid-Cap Growth ETF	0.539%	0.076%	545,929	416	2024-10-31
State St S&P Midcap® Indx SL Cl II	0.453%	0.000%	458,945	0	2024-10-31

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Total Stock Mkt Idx Inv	3.163%	0.079%	3,202,736	2,532	2024-09-30
iShares Core S&P Mid-Cap ETF	3.140%	0.054%	3,179,320	1,728	2024-10-31
Vanguard Instl Ttl Stck Mkt Idx Tr	3.043%	2.151%	2,989,608	62,942	2023-03-31
Vanguard Small Cap Index	2.497%	-0.693%	2,527,816	-17,642	2024-09-30
BB Biotech AG Ord	1.837%	-1.219%	1,860,000	-22,953	2024-09-30
Vanguard Institutional Extnd Mkt Idx Tr	1.493%	-1.879%	1,511,150	-28,944	2024-09-30
SPDR® S&P Biotech ETF	1.471%	-1.424%	1,489,130	-21,504	2024-10-31
Vanguard Small Cap Growth Index Inv	1.379%	-0.832%	1,395,750	-11,707	2024-09-30
Vanguard Extended Market Index Investor	1.390%	0.389%	1,357,042	5,261	2023-08-31
Janus Henderson Enterprise D	1.115%	0.000%	1,071,799	0	2022-09-30
Janus Inst Mid Cap Growth CF	1.115%	0.000%	1,071,799	0	2022-09-30
SPDR® S&P MIDCAP 400 ETF Trust	0.796%	0.371%	805,903	2,975	2024-09-30
Dodge & Cox Stock I	0.692%	0.000%	700,288	0	2024-09-30
iShares Biotechnology ETF	0.686%	-0.746%	694,961	-5,222	2024-10-31
JPM US Mid Cap Growth-MA	0.670%	171.177%	658,688	415,788	2023-09-30
iShares MSCI USA Min Vol Factor ETF	0.649%	-0.189%	656,595	-1,240	2024-10-31
American Century Heritage Inv	0.658%	-23.123%	646,935	-194,581	2023-09-30
American Century US Opport. Mid Cap Gr	0.658%	-23.123%	646,935	-194,581	2023-09-30
iShares S&P Mid-Cap 400 Growth ETF	0.622%	-0.049%	629,574	-309	2024-10-31
T. Rowe Price Health Sciences	0.618%	-8.585%	625,609	-58,749	2024-09-30
State St Russell Sm/Mid Cp® Indx NL Cl C	0.608%	-3.464%	615,853	-22,100	2024-10-31
Janus Henderson Global Life Sciences D	0.614%	-9.878%	590,365	-64,705	2022-09-30
Janus Henderson Global Life Sciences	0.614%	-9.878%	590,365	-64,705	2022-09-30
Fidelity Extended Market Index	0.582%	-2.738%	588,816	-16,577	2024-09-30
Eagle Mid-Cap Growth - Institutional	0.581%	-8.742%	588,660	-56,389	2024-09-30
Hartford MidCap Y	0.583%	-0.462%	586,362	-2,721	2024-02-29
JPMorgan Mid Cap Growth I	0.555%	0.000%	560,488	0	2024-07-31
JPM US Mid Cap Growth-Composite	0.555%	-14.589%	560,488	-95,734	2024-06-30
iShares Russell Mid-Cap Growth ETF	0.539%	0.076%	545,929	416	2024-10-31
Fidelity® Extended Market Index	0.529%	1.976%	519,395	10,066	2023-10-31
Janus Global Life Science A USD	0.539%	-12.749%	517,834	-75,663	2022-09-30
Vanguard Explorer Inv	0.506%	-4.025%	512,613	-21,500	2024-09-30
Janus Henderson Triton D	0.513%	-7.375%	500,984	-39,888	2023-06-30
BNP Paribas Health Cr Innovtr Cl Cap	0.489%	0.135%	482,275	651	2023-12-31
Pictet-Biotech P USD	0.477%	20.601%	479,509	81,908	2024-04-30
Janus Henderson US SMID Cap Growth	0.476%	0.000%	478,830	0	2023-12-31
Carillon Eagle Mid Cap Growth A	0.466%	-5.758%	471,315	-28,798	2024-09-30
State St S&P Midcap® Indx SL Cl II	0.453%	0.000%	458,945	0	2024-10-31